Education
About Us
Working with TipRanks
Follow Us
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 559.00K | $ 43.26M | $ 25.38M | $ 21.66M | $ 12.41M |
| Gross Profit | $ 344.00K | $ 31.45M | $ 15.06M | $ 8.19M | $ 4.96M |
| Operating Income | $ -89.75M | $ -63.32M | $ -49.60M | $ -61.04M | $ -45.81M |
| EBITDA | $ -60.80M | $ -48.99M | $ -49.78M | $ -60.44M | $ -45.42M |
| Net Income | $ -88.61M | $ -45.31M | $ -43.27M | $ -50.33M | $ -39.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 85.11M | $ 147.33M | $ 68.79M | $ 71.14M | $ 73.54M |
| Total Assets | $ 131.44M | $ 202.63M | $ 119.45M | $ 107.50M | $ 96.19M |
| Total Debt | $ -160.00K | $ 117.00K | $ 346.00K | $ 446.00K | $ 137.00K |
| Net Debt | $ -11.44M | $ -121.21M | $ -68.44M | $ -54.37M | $ -73.40M |
| Total Liabilities | $ 51.31M | $ 68.61M | $ 97.45M | $ 85.43M | $ 87.67M |
| Stockholders' Equity | $ 46.24M | $ 134.02M | $ 21.99M | $ 22.07M | $ 8.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -62.33M | $ -67.85M | $ -39.40M | $ -57.59M | $ 7.39M |
| Operating Cash Flow | $ -62.27M | $ -67.64M | $ -39.35M | $ -57.04M | $ 9.19M |
| Investing Cash Flow | $ -35.70M | $ -21.97M | $ 16.43M | $ -20.50M | $ 11.71M |
| Financing Cash Flow | $ 11.16K | $ 142.09M | $ 25.16M | $ 52.58M | $ 41.45M |